制造Necator americanus作为一种传染性挑战剂:加速人类虫疫苗开发
Guacyara Erwin1, Larissa Scholte1, Rafaela Saes1
1Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, 20052, United States of America.
Microbial pathogenesis
|April 17, 2025
概括
该研究详细介绍了用于疫苗挑战模型的传染性虫幼虫 (NaL3) 的cGMP生产情况. 这确保了N. americanus Glutathione-S-Transferase-1 (Na-GST-1) 人类虫候选疫苗的安全性和有效性测试.
科学领域:
- 寄生虫学的寄生虫学
- 疫苗学 疫苗学 疫苗学
- 制造业 制造业 制造业 制造业 制造业
背景情况:
- 虫感染影响全球4.5亿人,导致严重的残疾.
- 美国的N.Glutathione-S-Transferase-1 (Na-GST-1) 是一个有前途的人类虫疫苗候选人.
- 有效性测试需要可靠的传染性挑战剂.
研究的目的:
- 描述目前的良好制造实践 (cGMP) 在第三阶段N. americanus幼虫 (NaL3) 的生产.
- 建立NaL3作为疫苗开发的标准化传染性挑战剂.
- 为了支持Na-GST-1候选疫苗的"概念验证"研究.
主要方法:
- NaL3是由使用修改后的哈拉达和莫里方法从感染的人类便样本中生成的.
- 生产遵循cGMP指南,以确保质量和一致性.
- 批量释放测试包括纯度,生存能力和品种评估.
主要成果:
- 24个生产运行平均每批947 NaL3的产量.
- 所有生产的NaL3批量都符合临床使用的释放标准.
- 在虫疫苗挑战模型中,NaL3成功地用于接种39名参与者的疫苗.
结论:
- 根据cGMP,NaL3的制造是可行的,对于虫疫苗的开发至关重要.
- 标准化的NaL3生产使得像Na-GST-1这样的候选疫苗的严格有效性测试成为可能.
- 这项工作促进了在特有地区进行大规模实地试验的进展.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...


